| 04/28/2026 3:29 PM | Context Therapeutics (1842952) Filer | Form ARS | |
| 04/28/2026 3:15 PM | Context Therapeutics (1842952) Filer | Form DEFA14A | |
| 04/17/2026 3:29 PM | Context Therapeutics (1842952) Filer | Form PRE 14A | |
| 04/02/2026 6:41 AM | Context Therapeutics (1842952) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/23/2026 4:08 PM | Context Therapeutics (1842952) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/23/2026 3:22 PM | Context Therapeutics (1842952) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/23/2026 3:09 PM | Context Therapeutics (1842952) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/13/2026 3:09 PM | Context Therapeutics (1842952) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 3:18 PM | Chagin Karen Deborah (2070710) Reporting Context Therapeutics (1842952) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:21 PM | Context Therapeutics (1842952) Issuer Minai-Azary Jennifer Lynn (1844398) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:24 PM | Context Therapeutics (1842952) Issuer Levit Alex C. (1862840) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CNTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/23/2026 3:13 PM | Context Therapeutics (1842952) Issuer Lehr Martin A. (1861989) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 3:41 PM | Context Therapeutics (1842952) Subject Soleus Capital Master Fund, L.P. (1812275) Filed by | Form SCHEDULE 13G | |
| 01/08/2026 6:43 AM | Context Therapeutics (1842952) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/05/2025 3:21 PM | Context Therapeutics (1842952) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/24/2025 3:01 PM | Context Therapeutics (1842952) Filer | Form 424B5 | |
| 10/24/2025 3:02 PM | Context Therapeutics (1842952) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/02/2025 6:32 AM | Context Therapeutics (1842952) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2025 1:28 PM | Avidity Partners Management LP (1791827) Filed by Context Therapeutics (1842952) Subject | Form SCHEDULE 13G/A | |
| 06/12/2025 4:23 PM | Context Therapeutics (1842952) Issuer West Linda (1805257) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 4:24 PM | Context Therapeutics (1842952) Issuer Walker Luke Nathaniel (1701440) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 4:25 PM | Context Therapeutics (1842952) Issuer Stacey Jennifer Evans (1321326) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 4:27 PM | Context Therapeutics (1842952) Issuer Smith Karen L. (1639637) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 4:28 PM | Context Therapeutics (1842952) Issuer Kantoff Philip W. (1866025) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 4:30 PM | Context Therapeutics (1842952) Issuer Pasternak Andy (1792746) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2025 4:26 PM | Context Therapeutics (1842952) Issuer Lehr Martin A. (1861989) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2025 4:22 PM | Context Therapeutics (1842952) Issuer Minai-Azary Jennifer Lynn (1844398) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2025 4:23 PM | Context Therapeutics (1842952) Issuer Levit Alex C. (1862840) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 4:13 PM | Chagin Karen Deborah (2070710) Reporting Context Therapeutics (1842952) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/09/2025 4:22 PM | Chagin Karen Deborah (2070710) Reporting Context Therapeutics (1842952) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2025 6:34 AM | Context Therapeutics (1842952) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2025 7:38 AM | Context Therapeutics (1842952) Subject Deep Track Capital, LP (1856083) Filed by | Form SCHEDULE 13G/A | |
| 05/09/2025 12:08 PM | Context Therapeutics (1842952) Subject FRANKLIN RESOURCES INC (38777) Filed by | Form SCHEDULE 13G/A | |